Cargando…
SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
Ovarian cancer is a disease with increasing incidence worldwide, and there is an urgent need for chemotherapy and biological targeted therapy. Epithelial-mesenchymal transformation (EMT) is an important initiation stage for tumor cells to acquire the ability to invade and metastasize. A growing numb...
Autores principales: | Xu, Qiao Ping, Deng, Kui, Zhang, Zhen, Shang, Hongkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901157/ https://www.ncbi.nlm.nih.gov/pubmed/36747204 http://dx.doi.org/10.1186/s13048-023-01103-7 |
Ejemplares similares
-
Mouse Slfn8 and Slfn9 genes complement human cells lacking SLFN11 during the replication stress response
por: Alvi, Erin, et al.
Publicado: (2023) -
The Long Noncoding RNA MEG3 Retains Epithelial-Mesenchymal Transition by Sponging miR-146b-5p to Regulate SLFN5 Expression in Breast Cancer Cells
por: Gu, Xuefeng, et al.
Publicado: (2022) -
Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase
por: Garvie, Colin W., et al.
Publicado: (2021) -
Mechanistic understanding of human SLFN11
por: Metzner, Felix J., et al.
Publicado: (2022) -
SLFN14 gene mutations associated with bleeding
por: Stapley, Rachel J., et al.
Publicado: (2019)